Evonik, one of the world leaders in specialty chemicals, inaugurated its new office in Pakistan on December 4, 2018. The legal entity was established to support the company’s strategic and long-term growth plans in the country.
 |
|
(L to R) Peter Meinshausen, President, Evonik Asia Pacific South; Waqar Alam, Managing Director, Evonik Pakistan Pvt Ltd; Eugen Wollfarth, Consul General of Germany, Karachi; Asif Sheikh, Vice President, Karachi Chamber of Commerce |
Located in the megacity of Karachi, the new office represents another important milestone for Evonik since its first representative office was opened in the country in 2004. Tapping into Pakistan’s emerging and dynamic business landscape, the company will focus on strengthening its local presence as well as expanding capabilities for its various business lines including Animal Nutrition, Silica, Oil Additives, Health Care, Personal Care and Interface & Performance.
“With our dedicated local sales and business development team, we are now even better positioned to serving our customers. At the same time, we remain committed to contributing to Pakistan’s economic development through our innovative, sustainable solutions,” said Peter Meinshausen, Regional President of Evonik Asia Pacific South during the opening ceremony. “Over the past decade, we have built strong relationships with our customer base here. We see a lot of potential in several areas and setting up a full-fledged entity in Pakistan is a logical step in our growth strategy.”
Evonik Pakistan is a wholly-owned subsidiary of Evonik Industries. Active in over 100 countries around the world, Evonik has a strong product portfolio for multiple industry applications including but not limited to Health Care, Animal Nutrition, Resource Efficiency, and Performance Materials.
About Evonik
Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-orientated innovative prowess and a trustful and performance-oriented corporate culture form the heart of Evonik’s corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world with more than 36,000 employees. In fiscal 2017, the enterprise generated sales of €14.4 billion and an operating profit (adjusted EBITDA) of €2.36 billion.
